Interacting Drugs |
Bosentan vs Imatinib |
Security Level |
 |
Mechanism |
Imatinib: CYP3A4 Inducers (Strong) may decrease the serum concentration of Imatinib. |
Management |
Avoid concurrent use of imatinib with strong CYP3A4 inducers when possible. If such a combination must be used, increase imatinib dose by at least 50% and monitor the patient's clinical response closely. |
Bosentan vs Imatinib
Post Review about Bosentan vs Imatinib Click here to cancel reply.
Other Interactions of Bosentan
Other Interactions of Imatinib
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.